Literature DB >> 10467105

Benzoquinoid ansamycins (herbimycin A and geldanamycin) interfere with the maturation of growth factor receptor tyrosine kinases.

M Sakagami1, P Morrison, W J Welch.   

Abstract

Benzoquinoid ansamycins, such as herbimycin A (HA) and geldanamycin (GA), are antibiotics that exhibit anti-tumor effects. These compounds have been shown to result in the intracellular depletion of important growth signaling molecules. Recently, GA has been shown to bind tightly to Hsp90, thereby implicating Hsp90 as a possible chaperone for those signaling molecules adversely affected by the benzoquinoid ansamycins. Here we have investigated the effects of HA and GA on the synthesis, maturation and stability of different protein tyrosine kinases. Exposing cells to either compound blocked normal maturation of the epidermal growth factor (EGF) receptor, platelet-derived growth factor (PDGF) receptor, and pp60(v-src). We show that only the nascent forms of the EGF and PDGF receptors are degraded under these conditions. Once the newly synthesized receptors had been translocated into the endoplasmic reticulum membrane, addition of the drugs no longer affected their stability. For the cytoplasmic tyrosine kinase, pp60(v-src), both the nascent as well as the mature forms of the protein were degraded in cells treated with the drugs. We discuss these observations as they pertain to the possible role of Hsp90 as a substrate-specific molecular chaperone, perhaps involved in the maturation and/or stability of proteins important for growth control. Copyright 1999 Harcourt Brace and Co. Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10467105      PMCID: PMC312914          DOI: 10.1006/csac.1998.0115

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  14 in total

Review 1.  Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones.

Authors:  H J Ochel; K Eichhorn; G Gademann
Journal:  Cell Stress Chaperones       Date:  2001-04       Impact factor: 3.667

2.  The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.

Authors:  T Schnaider; J Somogyi; P Csermely; M Szamel
Journal:  Cell Stress Chaperones       Date:  2000-01       Impact factor: 3.667

3.  Inhibition of HSP90 in Trypanosoma cruzi induces a stress response but no stage differentiation.

Authors:  Sebastian E B Graefe; Martina Wiesgigl; Iris Gaworski; Andrea Macdonald; Joachim Clos
Journal:  Eukaryot Cell       Date:  2002-12

Review 4.  Chaperone proteins and brain tumors: potential targets and possible therapeutics.

Authors:  Michael W Graner; Darell D Bigner
Journal:  Neuro Oncol       Date:  2005-07       Impact factor: 12.300

Review 5.  Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity.

Authors:  L Neckers; T W Schulte; E Mimnaugh
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

6.  Pnck induces ligand-independent EGFR degradation by probable perturbation of the Hsp90 chaperone complex.

Authors:  Tushar B Deb; Annie H Zuo; Youhong Wang; Robert J Barndt; Amrita K Cheema; Surojeet Sengupta; Christine M Coticchia; Michael D Johnson
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-16       Impact factor: 4.249

7.  Geldanamycin selectively targets the nascent form of ERBB3 for degradation.

Authors:  Candice S Gerbin; Ralf Landgraf
Journal:  Cell Stress Chaperones       Date:  2010-01-19       Impact factor: 3.667

8.  Non-invasive PET imaging of EGFR degradation induced by a heat shock protein 90 inhibitor.

Authors:  Gang Niu; Weibo Cai; Kai Chen; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2007-12-22       Impact factor: 3.488

9.  Apoptosis caused by Hsp90 inhibitor geldanamycin in Leishmania donovani during promastigote-to-amastigote transformation stage.

Authors:  Qiaoli Li; Ying Zhou; Chenjiang Yao; Xiaoping Ma; Lianyun Wang; Wangjie Xu; Zhaoxia Wang; Zhongdong Qiao
Journal:  Parasitol Res       Date:  2009-08-19       Impact factor: 2.289

10.  Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel.

Authors:  Ayana Sawai; Sarat Chandarlapaty; Heidi Greulich; Mithat Gonen; Qing Ye; Carlos L Arteaga; William Sellers; Neal Rosen; David B Solit
Journal:  Cancer Res       Date:  2008-01-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.